The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales
- 6 December 2001
- Vol. 20 (9-10) , 1316-1330
- https://doi.org/10.1016/s0264-410x(01)00473-x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Immunogenicity and reactogenicity of acellular diphtheria/tetanus/pertussis vaccines given as a pre-school booster: effect of simultaneous administration of MMRVaccine, 2001
- Do we need to boost pertussis immunization within the existing UK vaccination schedule?Journal of Public Health, 2000
- Morbidity of Pertussis in Adolescents and AdultsThe Journal of Infectious Diseases, 2000
- Changing Epidemiology of Pertussis in the United States: Increasing Reported Incidence Among Adolescents and Adults, 1990‐1996Clinical Infectious Diseases, 1999
- Economic evaluation of pertussis prevention by whole-cell and acellular vaccine in GermanyEuropean Journal of Pediatrics, 1998
- Prevalence and incidence of adult pertussis in an urban populationPublished by American Medical Association (AMA) ,1996
- Pertussis infection in adults with persistent coughPublished by American Medical Association (AMA) ,1995
- Pertussis and pertussis vaccine. Reanalysis of benefits, risks, and costsJAMA, 1984
- Distribution of immunity to pertussis in the population of England and WalesEpidemiology and Infection, 1984
- Pertussis Vaccine — An Analysis of Benefits, Risks and CostsNew England Journal of Medicine, 1979